Effects of the full dopamine D1 receptor agonist dihydrexidine in Parkinson's disease
Blanchet, P J, Fang, J, Gillespie, M, Sabounjian, L, Locke, K W, Gammans, R, Mouradian, M M, Chase, T N
Published in Clinical neuropharmacology (01.11.1998)
Get more information
Published in Clinical neuropharmacology (01.11.1998)
Journal Article
Characterization of the discriminative stimulus effects of physostigmine in the rat
LOCKE, K. W, GORNEY, B, CORNFELDT, M, FIELDING, S
Published in The Journal of pharmacology and experimental therapeutics (01.07.1989)
Get full text
Published in The Journal of pharmacology and experimental therapeutics (01.07.1989)
Journal Article
Cardiorespiratory effects of the novel opioid analgesic HP 736 in the anesthetized dog and conscious goat
HUBBARD, J., LOCKE, K. W, VANSELOUS, C. L, HAMER, R. R. L, GLAMKOWSKI, E. J, FIELDING, S, FORSTER, K. W, FORSTER, H. V, BRICE, A. G, PAN, L. G, LOWRY, T. F, FORSTER, A.-M. L, FORSTER, M. A, CORNFELDT, M
Published in The Journal of pharmacology and experimental therapeutics (01.03.1992)
Get full text
Published in The Journal of pharmacology and experimental therapeutics (01.03.1992)
Journal Article
Synergistic effects of citicoline and MK-801 in temporary experimental focal ischemia in rats
Onal, M Z, Li, F, Tatlisumak, T, Locke, K W, Sandage, Jr, B W, Fisher, M
Published in Stroke (1970) (01.05.1997)
Published in Stroke (1970) (01.05.1997)
Get full text
Journal Article
D1 agonist dihydrexidine releases acetylcholine and improves cognitive performance in rats
STEELE, T. D, HODGES, D. B, LEVESQUE, T. R, LOCKE, K. W
Published in Pharmacology, biochemistry and behavior (01.10.1997)
Published in Pharmacology, biochemistry and behavior (01.10.1997)
Get full text
Journal Article
Recommendations for standards regarding preclinical neuroprotective and restorative drug development
Finklestein, Seth P, Fisher, Marc, Furlan, Anthony J, Goldstein, Larry B
Published in Stroke (1970) (01.12.1999)
Published in Stroke (1970) (01.12.1999)
Get full text
Journal Article
A phase I pharmacokinetic (PK) and pharmacodynamic (PD) study of MN-029, a novel vascular disrupting agent (VDA), in patients (pts) with advanced solid tumors
Ricart, A. D., Cooney, M., Sarantopoulos, J., Brell, J., Locke, K. W., Gammans, R. E., Medina, G., Zambito, A., Tolcher, A. W., Remick, S. C.
Published in Journal of clinical oncology (20.06.2006)
Published in Journal of clinical oncology (20.06.2006)
Get full text
Journal Article